Clinical Trial Update: Hemodynamic Effects of ARNI on Noninvasive Pressure-volume Analysis in Patients With Chronic Heart Failure

View source ↗

Summary

A completed clinical trial evaluating the hemodynamic effects of an ARNI regimen on noninvasive pressure-volume measurements in patients with chronic heart fail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

Sponsor: University of Leipzig | Conditions: Heart Failure With Reduced Ejection Fraction | Status: COMPLETED